共 50 条
- [4] Sacituzumab Govitecan in Metastatic Breast Cancer [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03):
- [5] Cost-effectiveness of sacituzumab govitecan in hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer [J]. FRONTIERS IN ONCOLOGY, 2023, 13
- [7] Sacituzumab Govitecan in Metastatic Breast Cancer REPLY [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (03):